OptiNose, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
OPTN on Nasdaq
Industry
Pharmaceutical Preparations
Location
777 Township Line Road, Suite 300, Yardley, PA

Insiders trading volume in the past year

OptiNose, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
MVM Partners, LLC 10%+ Owner $16.8M Dec 31, 2022
MVM Partners LLP 10%+ Owner $14.4M Nov 18, 2021
Peter K. Miller Chief Executive Officer, Director $1.1M Jan 13, 2023
Ramy A. Mahmoud Chief Executive Officer, Director $603K -$261K -30.2% Dec 17, 2024
Paul Spence Jr. Chief Commercial Officer $331K Feb 28, 2024
Michael F. Marino III Chief Legal Officer & Corp Sec $239K -$96.2K -28.7% Dec 17, 2024
Victor M. Clavelli Chief Commercial Officer $230K Dec 15, 2022
Keith A. Goldan Chief Financial Officer $163K Mar 16, 2022
Anthony J. Krick Chief Accounting Officer $160K -$13K -7.47% Jul 17, 2024
Terry Kohler Chief Financial Officer $131K Oct 7, 2024
Michele Janis Acting Chief Financial Officer $56.3K Dec 15, 2022
Avista Capital Partners II GP, LLC 10%+ Owner $55.6K May 12, 2023
Tomas J. Heyman Director Jun 6, 2024
Catherine E. Owen Director Jun 6, 2024
Joseph C. Scodari Director Jun 8, 2022
Groenhuysen Wilhelmus Cm Director Jun 6, 2024
Kyle Dempsey Director Jun 6, 2024
Sandra L. Helton Director Jun 6, 2024
R. John Fletcher Director Jun 6, 2024
Eric Bednarski Director Jun 6, 2024

Recent Insider Transactions by Companies or Individuals for OptiNose, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.